Skip to content
MARK EGLY

Diseases in Mark's patent

Explore autoimmune, cancer, neurological, respiratory, and other conditions named in Mark Egly's patent. Filter by category to find education pages with research hypotheses clearly labeled.

Research hypothesis, not medical advice

The connections described on this page come from Mark Egly's patent filing and ongoing research. They are not established medical facts. Always work with your physician for diagnosis and treatment.

  • Acute disseminated encephalomyelitis

    Education on Acute disseminated encephalomyelitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Acute Respiratory Distress Syndrome

    Education on Acute Respiratory Distress Syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Addison's disease

    Education on Addison's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Adiposis dolorosa

    Education on Adiposis dolorosa and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Adult-onset Still's disease

    Education on Adult-onset Still's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Alopecia areata

    Education on Alopecia areata and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Alzheimer's disease

    Hypothesis labeled education on Alzheimer's disease within Mark Egly Foundation neurological research pages.

  • Amyotrophic lateral sclerosis

    Also known as: ALS, Lou Gehrig's Disease

    Education on Amyotrophic lateral sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Anemia and thrombocytopenia

    Education on Anemia and thrombocytopenia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Aneurysms

    Education on Aneurysms and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Ankylosing spondylitis

    Education on Ankylosing spondylitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Anti-glomerular basement membrane nephritis

    Education on Anti-glomerular basement membrane nephritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Anti-N-methyl-D-aspartate receptor encephalitis

    Education on Anti-N-methyl-D-aspartate receptor encephalitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

    Education on Anti-neutrophil cytoplasmic antibody-associated vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Antiphospholipid syndrome

    Education on Antiphospholipid syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Antisynthetase syndrome

    Education on Antisynthetase syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Aplastic anemia

    Education on Aplastic anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Atherosclerosis

    Education on Atherosclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune angioedema

    Education on Autoimmune angioedema and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune enteropathy

    Education on Autoimmune enteropathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune hemolytic anemia

    Education on Autoimmune hemolytic anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune hepatitis

    Education on Autoimmune hepatitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune lymphoproliferative syndrome

    Education on Autoimmune lymphoproliferative syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune neutropenia

    Education on Autoimmune neutropenia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune oophoritis

    Education on Autoimmune oophoritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune orchitis

    Education on Autoimmune orchitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune pancreatitis

    Education on Autoimmune pancreatitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune polyendocrine syndrome

    Education on Autoimmune polyendocrine syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune polyendocrine syndrome type 2

    Education on Autoimmune polyendocrine syndrome type 2 and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune polyendocrine syndrome type 3

    Education on Autoimmune polyendocrine syndrome type 3 and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune progesterone dermatitis

    Education on Autoimmune progesterone dermatitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune retinopathy

    Education on Autoimmune retinopathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune thrombocytopenic purpura

    Education on Autoimmune thrombocytopenic purpura and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune thyroiditis

    Education on Autoimmune thyroiditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune urticaria

    Education on Autoimmune urticaria and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Autoimmune uveitis

    Education on Autoimmune uveitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Balo concentric sclerosis

    Education on Balo concentric sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Behcet's disease

    Education on Behcet's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Bone marrow disease

    Education on Bone marrow disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Breast cancer

    Education on breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Bullous pemphigoid

    Education on Bullous pemphigoid and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Cancer

    Education on Cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Celiac disease

    Education on Celiac disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Chronic fatigue syndrome

    Education on Chronic fatigue syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Chronic inflammatory demyelinating polyneuropathy

    Education on Chronic inflammatory demyelinating polyneuropathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Churg-Strauss syndrome

    Education on Churg-Strauss syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Cicatrical pemphigoid

    Education on Cicatrical pemphigoid and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Circulation problems

    Education on Circulation problems and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Cogan's syndrome

    Also known as: autoimmune inner ear disease

    Education on Cogan's syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Cold agglutinin disease

    Education on Cold agglutinin disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Colorectal cancer

    Education on Colorectal cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Complex regional pain syndrome

    Education on Complex regional pain syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • COPD

    Also known as: Chronic Obstructive Pulmonary Disease, Alpha-1 COPD

    Education on COPD as a common lung outcome of Alpha-1 Antitrypsin Deficiency, with guidance on symptoms, testing, and established care pathways.

  • Coronavirus

    Education on Coronavirus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Crest syndrome

    Also known as: limited scleroderma

    Education on Crest syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Crohn's disease

    Education on Crohn's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Cushing's disease

    Education on Cushing's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Cystic fibrosis

    Education on Cystic fibrosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Demyelinating diseases

    Education on Demyelinating diseases and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Depression

    Education on Depression and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Dermatitis herpetiformis

    Education on Dermatitis herpetiformis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Dermatomyositis

    Education on Dermatomyositis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Diabetes

    Education on Diabetes and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Diabetes mellitus type 1

    Education on Diabetes mellitus type 1 and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Discoid lupus erythematosus

    Education on Discoid lupus erythematosus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Ductal carcinoma in Situ

    Also known as: DCIS, breast cancer

    Education on Ductal carcinoma in Situ and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Ears and hearing

    Education on Ears and hearing and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Eclampsia, preeclampsia, and hypertension

    Education on Eclampsia, preeclampsia, and hypertension and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Emphysema

    Also known as: Hereditary emphysema, Alpha-1 emphysema

    Education on emphysema and hereditary emphysema linked to Alpha-1 Antitrypsin Deficiency, including testing and care pathways.

  • Endometriosis

    Education on Endometriosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Enthesitis

    Education on Enthesitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Enthesitis-related arthritis

    Education on Enthesitis-related arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Eosinophilic esophagitis

    Education on Eosinophilic esophagitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Eosinophilic fasciitis

    Education on Eosinophilic fasciitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Epidermolysis bullosa acquisita

    Education on Epidermolysis bullosa acquisita and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Epilepsy

    Education on Epilepsy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Erythema nodosum

    Education on Erythema nodosum and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Esophagus and GERD

    Education on Esophagus and GERD and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Essential mixed cryoglobulinemia

    Education on Essential mixed cryoglobulinemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Evans syndrome

    Education on Evans syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Eyes

    Education on Eyes and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Fibromyalgia

    Education on Fibromyalgia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Fibrosis

    Education on Fibrosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Gastritis

    Education on Gastritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Gestational pemphigoid

    Education on Gestational pemphigoid and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Giant cell arteritis

    Education on Giant cell arteritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Graves disease

    Education on Graves disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Graves ophthalmopathy

    Education on Graves ophthalmopathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Guillain-Barre syndrome

    Education on Guillain-Barre syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Hashimoto thyroiditis

    Education on Hashimoto thyroiditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Hashimoto's encephalopathy

    Education on Hashimoto's encephalopathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Heart disease

    Education on Heart disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Hemophilia

    Education on Hemophilia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Henoch-Schonlein purpura

    Education on Henoch-Schonlein purpura and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Hidradenitis suppurativa

    Education on Hidradenitis suppurativa and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Idiopathic inflammatory demyelinating diseases

    Education on Idiopathic inflammatory demyelinating diseases and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • IgG4-related disease

    Education on IgG4-related disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Inclusion body myositis

    Education on Inclusion body myositis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Infertility and sterility

    Education on Infertility and sterility and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Inflammation and chronic inflammation

    Education on Inflammation and chronic inflammation and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Inflammatory bowel disease

    Also known as: IBD

    Education on Inflammatory bowel disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Inflammatory breast cancer

    Also known as: IBC, breast cancer

    Education on Inflammatory breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Intermediate uveitis

    Education on Intermediate uveitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Interstitial cystitis

    Education on Interstitial cystitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Invasive ductal carcinoma

    Also known as: IDC, breast cancer

    Education on Invasive ductal carcinoma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Juvenile arthritis

    Education on Juvenile arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Kawasaki's disease

    Education on Kawasaki's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Kidney disease

    Education on Kidney disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Lambert-Eaton myasthenic syndrome

    Education on Lambert-Eaton myasthenic syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Leukocytoclastic vasculitis

    Education on Leukocytoclastic vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Lichen planus

    Education on Lichen planus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Lichen sclerosis

    Education on Lichen sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Ligneous conjunctivitis

    Education on Ligneous conjunctivitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Linear IgA disease

    Education on Linear IgA disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Lung cancer

    Also known as: Non-small cell lung cancer, NSCLC, Lung cancer prevention

    Education on lung cancer prevention searches and Mark Egly research hypotheses about Alpha-1 Antitrypsin biology. Not medical advice.

  • Lupus

    Education on lupus within the Mark Egly Foundation autoimmune research catalog, with hypothesis labeling.

  • Lupus nephritis

    Education on Lupus nephritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Lupus vasculitis

    Education on Lupus vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Lyme disease

    Education on Lyme disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Maternal hypoxia

    Education on Maternal hypoxia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Medullary (breast)

    Also known as: breast cancer

    Education on Medullary (breast) and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Melanoma and skin cancers

    Education on Melanoma and skin cancers and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Meniere's Disease

    Education on Meniere's Disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Metastatic breast cancer

    Also known as: MBC, breast cancer

    Education on Metastatic breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Microscopic colitis

    Education on Microscopic colitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Microscopic polyangiitis

    Also known as: MPA

    Education on Microscopic polyangiitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Mixed connective tissue disease

    Education on Mixed connective tissue disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Mooren's ulcer

    Education on Mooren's ulcer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Morphea

    Education on Morphea and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Mucha-Habermann disease

    Education on Mucha-Habermann disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Mucinous carcinoma

    Also known as: breast cancer

    Education on Mucinous carcinoma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Multiple sclerosis

    Education on Multiple sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Muscular dystrophy

    Education on Muscular dystrophy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Myasthenia gravis

    Education on Myasthenia gravis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Myocarditis

    Education on Myocarditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Myositis

    Education on Myositis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Neointimal lesions

    Education on Neointimal lesions and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Neuromyelitis optica

    Education on Neuromyelitis optica and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Optic neuritis

    Education on Optic neuritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Ord's thyroiditis

    Education on Ord's thyroiditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Ovarian cancer

    Education on Ovarian cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Paget disease (breast)

    Also known as: breast cancer

    Education on Paget disease (breast) and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Palindromic rheumatism

    Education on Palindromic rheumatism and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pancreatic cancer

    Education on Pancreatic cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Paraneoplastic cerebellar degeneration

    Education on Paraneoplastic cerebellar degeneration and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Parkinson's disease

    Also known as: Parkinson disease, Parkinsons

    Education on emerging research questions linking Parkinson's disease and Alpha-1 Antitrypsin, clearly labeled as hypothesis.

  • Parry-Romberg syndrome

    Education on Parry-Romberg syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Parsonage-Turner syndrome

    Education on Parsonage-Turner syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pediatric autoimmune neuropsychiatric disorder associated with streptococcus

    Education on Pediatric autoimmune neuropsychiatric disorder associated with streptococcus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pemphigus vulgaris

    Education on Pemphigus vulgaris and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Periodontal disease

    Education on Periodontal disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pernicious anemia

    Education on Pernicious anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pityriasis lichenoides et Varioliformis acuta

    Education on Pityriasis lichenoides et Varioliformis acuta and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pneumonia

    Education on Pneumonia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Poems Syndrome

    Education on Poems Syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Polyarteritis nodosa

    Education on Polyarteritis nodosa and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Polymyalgia rheumatica

    Education on Polymyalgia rheumatica and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Polymyositis Postmyocardial infarction syndrome

    Education on Polymyositis Postmyocardial infarction syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Postpericardiotomy syndrome (Sevuk et al)

    Education on Postpericardiotomy syndrome (Sevuk et al) and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Primary biliary cirrhosis

    Education on Primary biliary cirrhosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Primary sclerosing cholangitis

    Education on Primary sclerosing cholangitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Progressive inflammatory neuropathy

    Education on Progressive inflammatory neuropathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Prostate cancer

    Education on prostate cancer and Alpha-1 Antitrypsin research hypotheses, with clear separation from urology and oncology standard care.

  • Psoriasis

    Education on Psoriasis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Psoriatic arthritis

    Education on Psoriatic arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pure red cell aplasia

    Education on Pure red cell aplasia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Pyoderma gangrenosum

    Education on Pyoderma gangrenosum and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Raynaud phenomenon

    Education on Raynaud phenomenon and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Reactive arthritis

    Education on Reactive arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Relapsing polychondritis

    Education on Relapsing polychondritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Restless leg syndrome

    Education on Restless leg syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Retroperitoneal fibrosis

    Education on Retroperitoneal fibrosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Rheumatic fever

    Education on Rheumatic fever and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Rheumatoid arthritis

    Education on rheumatoid arthritis and Alpha-1 research hypotheses within the foundation autoimmune catalog.

  • Rheumatoid vasculitis

    Education on Rheumatoid vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Sarcoidosis

    Education on Sarcoidosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Schnitzler syndrome

    Education on Schnitzler syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Scleroderma

    Education on Scleroderma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Scoliosis, kyphosis, and related back issues

    Education on Scoliosis, kyphosis, and related back issues and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Sickle cell anemia

    Education on Sickle cell anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Sjogren's syndrome

    Education on Sjogren's syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Small cell carcinoma of the breast

    Also known as: breast cancer

    Education on Small cell carcinoma of the breast and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Stiff person syndrome

    Education on Stiff person syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Strokes

    Education on Strokes and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Subacute bacterial endocarditis

    Education on Subacute bacterial endocarditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Susac's Syndrome

    Education on Susac's Syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Sydenham chorea

    Education on Sydenham chorea and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Sympathetic ophthalmia

    Education on Sympathetic ophthalmia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Syringomyelia

    Education on Syringomyelia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Systemic lupus erythematosus

    Education on Systemic lupus erythematosus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Systemic scleroderma

    Education on Systemic scleroderma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Testicular cancer

    Education on Testicular cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Thrombocytopenia

    Education on Thrombocytopenia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Tolosa-Hunt syndrome

    Education on Tolosa-Hunt syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Transverse myelitis

    Education on Transverse myelitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Triple negative breast cancer

    Also known as: breast cancer

    Education on Triple negative breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Tubular carcinoma

    Also known as: breast cancer

    Education on Tubular carcinoma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Ulcerative colitis

    Education on Ulcerative colitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Undifferentiated connective tissue disease

    Education on Undifferentiated connective tissue disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Urticaria

    Education on Urticaria and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Urticarial vasculitis

    Education on Urticarial vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Uterine cancer

    Education on Uterine cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Vasculitis

    Education on Vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.

  • Vitiligo

    Education on Vitiligo and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.